Skip to main content
Top
Published in: Diabetologia 2/2005

01-02-2005 | Article

Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population

Authors: C. Meisinger, M. Heier, H. Loewel, The MONICA/KORA Augsburg Cohort Study

Published in: Diabetologia | Issue 2/2005

Login to get access

Abstract

Aims/hypothesis

To examine gender specific associations between sleep disturbance and incident type 2 diabetes mellitus in a representative population sample in Germany.

Methods

The study was based on 4,140 men and 4,129 women (aged 25–74 years) who participated in one of the three MONICA Augsburg surveys between 1984 and 1995, and who were free of diabetes at baseline. Incident cases of type 2 diabetes were assessed using a follow-up questionnaire in 1998. Gender specific hazard ratios were estimated from Cox proportional hazard models.

Results

A total of 119 cases of incident type 2 diabetes among men and 69 among women were registered during the mean follow-up period of 7.5 years. In both sexes, difficulty maintaining sleep was associated with a higher risk of type 2 diabetes. After adjustment for age, survey, hypertension, dyslipidemia, parental history of diabetes, history of angina pectoris, regular smoking, physical activity, alcohol intake, body mass index and education, the hazard ratio in men was 1.60 (95% CI: 1.05–2.45) and the hazard ratio in women was 1.98 (95% CI: 1.20–3.29). In contrast, difficulty initiating sleep was not associated with a significantly increased risk of developing type 2 diabetes mellitus after multivariable adjustment in both sexes in the present study.

Conclusions/interpretation

Difficulty maintaining sleep was associated with an increased risk of type 2 diabetes in men and women from the general population. Although, the causal pathway is not entirely clear, it seems that both insulin resistance and chronic low-grade systemic inflammation may be involved.
Literature
1.
go back to reference Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59:131–136CrossRef Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59:131–136CrossRef
2.
go back to reference Ayas NT, White DP, Manson JE et al. (2003) A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 163:205–209CrossRef Ayas NT, White DP, Manson JE et al. (2003) A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 163:205–209CrossRef
3.
go back to reference Resnick HE, Redline S, Shahar E et al. (2003) Diabetes and sleep disturbances. Diabetes Care 26:702–709 Resnick HE, Redline S, Shahar E et al. (2003) Diabetes and sleep disturbances. Diabetes Care 26:702–709
4.
go back to reference Jennum P, Schultz-Larsen K, Christensen N (1993) Snoring, sympathetic activity and cardiovascular risk factors in a 70-year-old population. Eur J Epidemiol 9:477–482CrossRef Jennum P, Schultz-Larsen K, Christensen N (1993) Snoring, sympathetic activity and cardiovascular risk factors in a 70-year-old population. Eur J Epidemiol 9:477–482CrossRef
5.
go back to reference Grunstein R, Wilcox I, Yang TS, Gould Y, Hedner J (1993) Snoring and sleep apnea in men, association with central obesity and hypertension. Int J Obes Relat Metab Disord 17:533–540 Grunstein R, Wilcox I, Yang TS, Gould Y, Hedner J (1993) Snoring and sleep apnea in men, association with central obesity and hypertension. Int J Obes Relat Metab Disord 17:533–540
6.
go back to reference Al-Delaimy W, Manson JE, Willett WC, Stampfer MJ, Hu FB (2002) Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 155:387–393CrossRef Al-Delaimy W, Manson JE, Willett WC, Stampfer MJ, Hu FB (2002) Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 155:387–393CrossRef
7.
go back to reference Elmasry A, Janson C, Lindberg E, Gislason T, Tageldin MA, Boman G (2000) The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med 248:13–20CrossRef Elmasry A, Janson C, Lindberg E, Gislason T, Tageldin MA, Boman G (2000) The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med 248:13–20CrossRef
8.
go back to reference Ayas NT, White DP, Al-Delaimy WK et al. (2003) A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26:380–384 Ayas NT, White DP, Al-Delaimy WK et al. (2003) A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26:380–384
9.
go back to reference Spiegel K, Leproult R, Van Cauter E (1999) Impact of sleep debt on metabolic and endocrine function. Lancet 354:1435–1439CrossRef Spiegel K, Leproult R, Van Cauter E (1999) Impact of sleep debt on metabolic and endocrine function. Lancet 354:1435–1439CrossRef
10.
go back to reference Keil U, Liese AD, Hense HW, Filipiak B, Döring A, Stieber J, Löwel H (1998) Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg Cohort Study 1984–1992. Eur Heart J 19:1197–1207PubMed Keil U, Liese AD, Hense HW, Filipiak B, Döring A, Stieber J, Löwel H (1998) Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg Cohort Study 1984–1992. Eur Heart J 19:1197–1207PubMed
11.
go back to reference Tunstall-Pedoe H, WHO MONICA Project Principal Investigators (1988). The World Health Organization MONICA project (monitoring of trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 34:105–114 Tunstall-Pedoe H, WHO MONICA Project Principal Investigators (1988). The World Health Organization MONICA project (monitoring of trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 34:105–114
12.
go back to reference Meisinger C, Thorand B, Schneider A, Stieber J, Doering A, Loewel H (2002) Sex differences in risk factors for incident type 2 diabetes mellitus. The MONICA Augsburg Cohort Study. Arch Intern Med 162:82–89PubMed Meisinger C, Thorand B, Schneider A, Stieber J, Doering A, Loewel H (2002) Sex differences in risk factors for incident type 2 diabetes mellitus. The MONICA Augsburg Cohort Study. Arch Intern Med 162:82–89PubMed
13.
go back to reference Kawakami N, Takatsuka N, Shimizu H (2004) Sleep disturbance and onset of type 2 diabetes. Diabetes Care 27:282–283 Kawakami N, Takatsuka N, Shimizu H (2004) Sleep disturbance and onset of type 2 diabetes. Diabetes Care 27:282–283
14.
go back to reference Stoohs RA, Faccini F, Guilleminault C (1996) Insulin resistance and sleep disordered breathing in healthy humans. Am J Respir Crit Care Med 154:170–174 Stoohs RA, Faccini F, Guilleminault C (1996) Insulin resistance and sleep disordered breathing in healthy humans. Am J Respir Crit Care Med 154:170–174
15.
go back to reference Punjabi NM, Sorkin JD, Katzel L, Goldberg A, Schwartz A, Smith PL (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677–682 Punjabi NM, Sorkin JD, Katzel L, Goldberg A, Schwartz A, Smith PL (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677–682
16.
go back to reference Akerstedt T, Nilsson PM (2003) Sleep as restitution: an introduction. J Intern Med 254:6–12CrossRef Akerstedt T, Nilsson PM (2003) Sleep as restitution: an introduction. J Intern Med 254:6–12CrossRef
17.
go back to reference Fletcher EC (1997) Sympathetic activity and blood pressure in the sleep apnea syndrome. Respiration 64(1):22–28 Fletcher EC (1997) Sympathetic activity and blood pressure in the sleep apnea syndrome. Respiration 64(1):22–28
18.
go back to reference Bratel T, Wennlund A, Carlstrom K (1999) Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 93:1–7CrossRef Bratel T, Wennlund A, Carlstrom K (1999) Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 93:1–7CrossRef
19.
go back to reference Scheen AJ, Van Cauter E (1998) The roles of time of day and sleep quality in modulating glucose regulation: clinical implications. Horm Res 49:191–201CrossRef Scheen AJ, Van Cauter E (1998) The roles of time of day and sleep quality in modulating glucose regulation: clinical implications. Horm Res 49:191–201CrossRef
20.
go back to reference Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566–570 Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566–570
21.
go back to reference Vgontzas AN, Bixler EO, Chrousos GP (2003) Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med 254:32–44CrossRef Vgontzas AN, Bixler EO, Chrousos GP (2003) Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med 254:32–44CrossRef
22.
go back to reference Meier-Ewert HK, Ridker PM, Rifai N et al. (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43:678–683CrossRef Meier-Ewert HK, Ridker PM, Rifai N et al. (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43:678–683CrossRef
23.
go back to reference Thorand B, Loewel H, Schneider A et al. (2003) C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men. Results from the MONICA Augsburg Cohort Study, 1984–1998. Arch Intern Med 163:93–99CrossRefPubMed Thorand B, Loewel H, Schneider A et al. (2003) C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men. Results from the MONICA Augsburg Cohort Study, 1984–1998. Arch Intern Med 163:93–99CrossRefPubMed
24.
go back to reference Parish JM, Shepard JW Jr (1990) Cardiovascular effects of sleep disorders. Chest 97:1220–1226 Parish JM, Shepard JW Jr (1990) Cardiovascular effects of sleep disorders. Chest 97:1220–1226
25.
go back to reference Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE (1998) “Syndrome Z”: the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 53[Suppl 3]:S25–S28 Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE (1998) “Syndrome Z”: the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 53[Suppl 3]:S25–S28
26.
go back to reference Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, Nathan DM, Manson JE (2001) The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 161:1717–1723CrossRef Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, Nathan DM, Manson JE (2001) The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 161:1717–1723CrossRef
27.
go back to reference Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH (1997) A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes Care 20:935–942PubMed Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH (1997) A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes Care 20:935–942PubMed
Metadata
Title
Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population
Authors
C. Meisinger
M. Heier
H. Loewel
The MONICA/KORA Augsburg Cohort Study
Publication date
01-02-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1634-x

Other articles of this Issue 2/2005

Diabetologia 2/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine